Praxis Precision Medicines clinical trials we track

Check company identity source

Phase 3 5 trials

Phase 2 / 3 2 trials

Phase 2 3 trials

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters

· 5 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 230 participants (planned). After: 255 participants (actual).

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: 24 Nov 2025. After: 14 May 2026.

Recruitment status changed

Before: Recruiting. After: Completed.

Check registry source

· 3 fields changed

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Sep 2025. After: 10 Oct 2025.

Recruitment status changed

Before: Enrolling by invitation. After: Active not recruiting.

Check registry source

· 5 fields changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: To assess the effect of PRAX-562 on the frequency of countable motor seizures in pediatric participants with DEEs. After: Measure: PART A (Cohorts 1 and 2) RDB: To evaluate the safety and tolerability of PRAX 562 in pediatric participants with SCN2A- and SCN8A- DEEs Measure: PART B (Cohorts 1 and 2) OLE: To evaluate the long-term safety and tolerability of PRAX-562 in pediatric participants with DEEs.

Planned enrollment decreased by 23 participants

Before: 100 participants (planned). After: 77 participants (planned).

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: 23 Mar 2026. After: 12 Nov 2025.

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source